{
  "success": true,
  "fetched_at": "2026-01-11T02:35:57.566015",
  "ticker": "4183",
  "ticker_full": "4183.T",
  "company_name": "MITSUI CHEMICALS INC",
  "company_info": {
    "name_en": "MITSUI CHEMICALS INC",
    "long_name": "Mitsui Chemicals, Inc.",
    "sector": "Basic Materials",
    "industry": "Specialty Chemicals",
    "website": "https://jp.mitsuichemicals.com/en",
    "employees": 17320,
    "country": "Japan",
    "city": "Tokyo",
    "address": "Tokyo Midtown Yaesu",
    "description": "Mitsui Chemicals, Inc. engages in the mobility, life and health care, basic and green materials, ICT, and other businesses worldwide. The company offers vision care materials, nonwoven fabrics and personal care materials, agricultural chemicals, and oral care materials; and elastomers, performance and polypropylene compounds, and other materials. It also provides semiconductor solutions, such as electronic component processing materials, optical materials, and lithium-ion battery materials; functional food packaging materials; imaging solutions, such as lens materials, materials for reflective films, and LCD and OLED sealing materials; battery material solutions; and converting solutions, including heat sealants, barrier coating materials, and packaging adhesives. In addition, the company offers petrochemicals, which comprise ethylene, propylene, high- and low-density polyethylene; basic chemicals, such as phenol, bisphenol, acetone, isopropyl alcohol, methyl isobutyl ketone, purified terephthalic acid, PET resin, ethylene oxide and glycol, hydroquinone, meta/para-cresol, ammonia, urea, and melamine; and polyurethane raw materials, as well as develops DNA microarrays. Further, it provides life care solutions, such as ophthalmic lens materials, photochromic lens materials, coating materials, nonwovens, breathable films, filtration devise, acrylamide, methacrylamide, and synthetic pulp; agrochemical products, including insecticides, fungicides, herbicides, non-crop specialty chemicals, pet medication ingredients; and medical solutions, restoratives, adhesives, artificial teeth, denture materials, impression, digital equipment/materials, medical materials, genetic testing, and contract genetic analysis services. It sells its products in Japan, China, Asia, the Americas, Europe, and internationally. Mitsui Chemicals, Inc. was founded in 1892 and is headquartered in Tokyo, Japan."
  },
  "price_trend": {
    "ma_5": {
      "ma_value": 2047.1,
      "deviation": -0.08,
      "trend": "down"
    },
    "ma_25": {
      "ma_value": 1971.18,
      "deviation": 3.77,
      "trend": "up"
    },
    "ma_75": {
      "ma_value": 1885.17,
      "deviation": 8.51,
      "trend": "up"
    },
    "ma_200": {
      "ma_value": 1730.5,
      "deviation": 18.2,
      "trend": "up"
    }
  },
  "financials": {
    "years": [
      {
        "year": 2025,
        "revenue": 1809164000000.0,
        "revenue_fmt": "¥1.8T",
        "gross_profit": 388292000000.0,
        "gross_profit_fmt": "¥3883億",
        "operating_income": 65907000000.0,
        "operating_income_fmt": "¥659億",
        "ebit": 86349000000.0,
        "ebit_fmt": "¥863億",
        "net_income": 32242000000.0,
        "net_income_fmt": "¥322億",
        "eps": 85.28,
        "operating_margin": 3.64,
        "total_assets": 2153953000000.0,
        "total_assets_fmt": "¥2.2T",
        "total_equity": 848284000000.0,
        "total_equity_fmt": "¥8483億",
        "total_debt": 737977000000.0,
        "total_debt_fmt": "¥7380億",
        "total_cash": 170615000000.0,
        "total_cash_fmt": "¥1706億",
        "equity_ratio": 39.38,
        "de_ratio": 0.87,
        "current_ratio": 1.72,
        "operating_cf": 200501000000.0,
        "operating_cf_fmt": "¥2005億",
        "investing_cf": -165012000000.0,
        "investing_cf_fmt": "-¥1650億",
        "financing_cf": -74437000000.0,
        "financing_cf_fmt": "-¥744億",
        "free_cf": 62095000000.0,
        "free_cf_fmt": "¥621億",
        "net_margin": 1.78,
        "roe": 3.8,
        "roa": 1.5
      },
      {
        "year": 2024,
        "revenue": 1749743000000.0,
        "revenue_fmt": "¥1.7T",
        "gross_profit": 370797000000.0,
        "gross_profit_fmt": "¥3708億",
        "operating_income": 61822000000.0,
        "operating_income_fmt": "¥618億",
        "ebit": 87994000000.0,
        "ebit_fmt": "¥880億",
        "net_income": 49999000000.0,
        "net_income_fmt": "¥500億",
        "eps": 131.5,
        "operating_margin": 3.53,
        "total_assets": 2215819000000.0,
        "total_assets_fmt": "¥2.2T",
        "total_equity": 862851000000.0,
        "total_equity_fmt": "¥8629億",
        "total_debt": 756758000000.0,
        "total_debt_fmt": "¥7568億",
        "total_cash": 210292000000.0,
        "total_cash_fmt": "¥2103億",
        "equity_ratio": 38.94,
        "de_ratio": 0.88,
        "current_ratio": 1.7,
        "operating_cf": 161339000000.0,
        "operating_cf_fmt": "¥1613億",
        "investing_cf": -123939000000.0,
        "investing_cf_fmt": "-¥1239億",
        "financing_cf": -26016000000.0,
        "financing_cf_fmt": "-¥260億",
        "free_cf": 7348000000.0,
        "free_cf_fmt": "¥73億",
        "net_margin": 2.86,
        "roe": 5.79,
        "roa": 2.26
      },
      {
        "year": 2023,
        "revenue": 1879547000000.0,
        "revenue_fmt": "¥1.9T",
        "gross_profit": 381493000000.0,
        "gross_profit_fmt": "¥3815億",
        "operating_income": 107305000000.0,
        "operating_income_fmt": "¥1073億",
        "ebit": 134676000000.0,
        "ebit_fmt": "¥1347億",
        "net_income": 82936000000.0,
        "net_income_fmt": "¥829億",
        "eps": 215.59,
        "operating_margin": 5.71,
        "total_assets": 2068203000000.0,
        "total_assets_fmt": "¥2.1T",
        "total_equity": 786827000000.0,
        "total_equity_fmt": "¥7868億",
        "total_debt": 738249000000.0,
        "total_debt_fmt": "¥7382億",
        "total_cash": 186310000000.0,
        "total_cash_fmt": "¥1863億",
        "equity_ratio": 38.04,
        "de_ratio": 0.94,
        "current_ratio": 1.57,
        "operating_cf": 101241000000.0,
        "operating_cf_fmt": "¥1012億",
        "investing_cf": -106340000000.0,
        "investing_cf_fmt": "-¥1063億",
        "financing_cf": 2542000000.0,
        "financing_cf_fmt": "¥25億",
        "free_cf": -36620000000.0,
        "free_cf_fmt": "-¥366億",
        "net_margin": 4.41,
        "roe": 10.54,
        "roa": 4.01
      },
      {
        "year": 2022,
        "revenue": 1612688000000.0,
        "revenue_fmt": "¥1.6T",
        "gross_profit": 378740000000.0,
        "gross_profit_fmt": "¥3787億",
        "operating_income": 121491000000.0,
        "operating_income_fmt": "¥1215億",
        "ebit": 153485000000.0,
        "ebit_fmt": "¥1535億",
        "net_income": 109990000000.0,
        "net_income_fmt": "¥1100億",
        "eps": 282.73,
        "operating_margin": 7.53,
        "total_assets": 1934965000000.0,
        "total_assets_fmt": "¥1.9T",
        "total_equity": 712654000000.0,
        "total_equity_fmt": "¥7127億",
        "total_debt": 666086000000.0,
        "total_debt_fmt": "¥6661億",
        "total_cash": 181152000000.0,
        "total_cash_fmt": "¥1812億",
        "equity_ratio": 36.83,
        "de_ratio": 0.93,
        "current_ratio": 1.46,
        "operating_cf": 92584000000.0,
        "operating_cf_fmt": "¥926億",
        "investing_cf": -205234000000.0,
        "investing_cf_fmt": "-¥2052億",
        "financing_cf": 89222000000.0,
        "financing_cf_fmt": "¥892億",
        "free_cf": -23632000000.0,
        "free_cf_fmt": "-¥236億",
        "net_margin": 6.82,
        "roe": 15.43,
        "roa": 5.68
      }
    ],
    "has_data": true
  },
  "dividends": {
    "history": [
      {
        "year": 2021,
        "amount": 52.5
      },
      {
        "year": 2022,
        "amount": 62.5
      },
      {
        "year": 2023,
        "amount": 65.0
      },
      {
        "year": 2024,
        "amount": 72.5
      },
      {
        "year": 2025,
        "amount": 75.0
      }
    ],
    "latest": 37.5,
    "has_data": true
  }
}